Dysregulated miRNAs in both diseases are primarily associated with apoptosis and inflammation, but miRNAs targeting the regulation of APP, L1CAM and the caspase family could see a reduction in neurodegeneration, as they are some common targets for dysregulation in both AD and PD [172]. This evidence concerns the gene APP and Parkinson disease.